Literature DB >> 26897369

Nobiletin: A Citrus Isolate to Make Sepsis Less Sour.

Patrick M Honore1,2, Rita Jacobs3, Inne Hendrickx3, Elisabeth De Waele3, Herbert D Spapen3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 26897369     DOI： 10.1007/s10753-016-0319-1

Source DB:  PubMed          Journal:  Inflammation        ISSN： 0360-3997            Impact factor:   4.092


× No keyword cloud information.
  20 in total

Review 1.  Sepsis: a roadmap for future research.

Authors:  Jonathan Cohen; Jean-Louis Vincent; Neill K J Adhikari; Flavia R Machado; Derek C Angus; Thierry Calandra; Katia Jaton; Stefano Giulieri; Julie Delaloye; Steven Opal; Kevin Tracey; Tom van der Poll; Eric Pelfrene
Journal:  Lancet Infect Dis       Date:  2015-04-19       Impact factor: 25.071

2.  In vitro evaluation of high mobility group box 1 protein removal with various membranes for continuous hemofiltration.

Authors:  Miho Yumoto; Osamu Nishida; Kazuhiro Moriyama; Yasuyo Shimomura; Tomoyuki Nakamura; Naohide Kuriyama; Yoshitaka Hara; Shingo Yamada
Journal:  Ther Apher Dial       Date:  2011-08       Impact factor: 1.762

Review 3.  Newly designed CRRT membranes for sepsis and SIRS--a pragmatic approach for bedside intensivists summarizing the more recent advances: a systematic structured review.

Authors:  Patrick M Honore; Rita Jacobs; Olivier Joannes-Boyau; Jouke De Regt; Elisabeth De Waele; Viola van Gorp; Willem Boer; Lies Verfaillie; Herbert D Spapen
Journal:  ASAIO J       Date:  2013 Mar-Apr       Impact factor: 2.872

4.  Drotrecogin alfa (activated) in adults with septic shock.

Authors:  V Marco Ranieri; B Taylor Thompson; Philip S Barie; Jean-François Dhainaut; Ivor S Douglas; Simon Finfer; Bengt Gårdlund; John C Marshall; Andrew Rhodes; Antonio Artigas; Didier Payen; Jyrki Tenhunen; Hussein R Al-Khalidi; Vivian Thompson; Jonathan Janes; William L Macias; Burkhard Vangerow; Mark D Williams
Journal:  N Engl J Med       Date:  2012-05-22       Impact factor: 91.245

5.  High-volume versus standard-volume haemofiltration for septic shock patients with acute kidney injury (IVOIRE study): a multicentre randomized controlled trial.

Authors:  Olivier Joannes-Boyau; Patrick M Honoré; Paul Perez; Sean M Bagshaw; Hubert Grand; Jean-Luc Canivet; Antoine Dewitte; Claire Flamens; Wilfried Pujol; Anne-Sophie Grandoulier; Catherine Fleureau; Rita Jacobs; Christophe Broux; Hervé Floch; Olivier Branchard; Stephane Franck; Hadrien Rozé; Vincent Collin; Willem Boer; Joachim Calderon; Bernard Gauche; Herbert D Spapen; Gérard Janvier; Alexandre Ouattara
Journal:  Intensive Care Med       Date:  2013-06-06       Impact factor: 17.440

6.  Reversing established sepsis with antagonists of endogenous high-mobility group box 1.

Authors:  Huan Yang; Mahendar Ochani; Jianhua Li; Xiaoling Qiang; Mahira Tanovic; Helena E Harris; Srinivas M Susarla; Luis Ulloa; Hong Wang; Robert DiRaimo; Christopher J Czura; Haichao Wang; Jesse Roth; H Shaw Warren; Mitchell P Fink; Matthew J Fenton; Ulf Andersson; Kevin J Tracey
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-26       Impact factor: 11.205

7.  The noninflammatory role of high mobility group box 1/Toll-like receptor 2 axis in the self-renewal of mammary cancer stem cells.

Authors:  Laura Conti; Stefania Lanzardo; Maddalena Arigoni; Roberta Antonazzo; Enrico Radaelli; Daniela Cantarella; Raffaele A Calogero; Federica Cavallo
Journal:  FASEB J       Date:  2013-08-22       Impact factor: 5.191

8.  Role of HMGB1 in apoptosis-mediated sepsis lethality.

Authors:  Shixin Qin; Haichao Wang; Renqi Yuan; Hui Li; Mahendar Ochani; Kanta Ochani; Mauricio Rosas-Ballina; Chris J Czura; Jared M Huston; Ed Miller; Xinchun Lin; Barbara Sherry; Anjali Kumar; Greg Larosa; Walter Newman; Kevin J Tracey; Huan Yang
Journal:  J Exp Med       Date:  2006-07-03       Impact factor: 14.307

9.  Anti-high mobility group box-1 monoclonal antibody treatment provides protection against influenza A virus (H1N1)-induced pneumonia in mice.

Authors:  Nobuyuki Nosaka; Masato Yashiro; Mutsuko Yamada; Yosuke Fujii; Hirokazu Tsukahara; Keyue Liu; Masahiro Nishibori; Akihiro Matsukawa; Tsuneo Morishima
Journal:  Crit Care       Date:  2015-06-11       Impact factor: 9.097

Review 10.  The role of high mobility group box 1 in innate immunity.

Authors:  Shin-Ae Lee; Man Sup Kwak; Sol Kim; Jeon-Soo Shin
Journal:  Yonsei Med J       Date:  2014-09       Impact factor: 2.759
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.